Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: A single-blind randomized controlled trial

Clin Transl Med. 2022 Sep;12(9):e895. doi: 10.1002/ctm2.895.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Intravenous
  • Aged
  • COVID-19 Drug Treatment*
  • Fatty Acids, Omega-3* / therapeutic use
  • Humans
  • Immunomodulation
  • Single-Blind Method

Substances

  • Fatty Acids, Omega-3